Stereotaxis (STXS): Price and Financial Metrics

Stereotaxis (STXS): $2.70

0.17 (-5.92%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

STXS Price/Volume Stats

Current price $2.70 52-week high $3.29
Prev. close $2.87 52-week low $1.33
Day low $2.50 Volume 571,800
Day high $2.89 Avg. volume 277,483
50-day MA $2.22 Dividend yield N/A
200-day MA $1.81 Market Cap 218.39M

STXS Stock Price Chart Interactive Chart >

STXS POWR Grades

  • STXS scores best on the Sentiment dimension, with a Sentiment rank ahead of 87.5% of US stocks.
  • STXS's strongest trending metric is Stability; it's been moving up over the last 26 weeks.
  • STXS ranks lowest in Value; there it ranks in the 19th percentile.

STXS Stock Summary

  • STXS has a market capitalization of $151,254,129 -- more than approximately just 23.39% of US stocks.
  • The ratio of debt to operating expenses for STEREOTAXIS INC is higher than it is for about just 17.83% of US stocks.
  • STXS's price/sales ratio is 5.13; that's higher than the P/S ratio of 79.32% of US stocks.
  • If you're looking for stocks that are quantitatively similar to STEREOTAXIS INC, a group of peers worth examining would be AMPL, VUZI, HCP, DOMO, and LMND.
  • STXS's SEC filings can be seen here. And to visit STEREOTAXIS INC's official web site, go to www.stereotaxis.com.

STXS Valuation Summary

  • STXS's price/earnings ratio is -6.7; this is 122.98% lower than that of the median Healthcare stock.
  • STXS's price/sales ratio has moved down 13.8 over the prior 236 months.

Below are key valuation metrics over time for STXS.

Stock Date P/S P/B P/E EV/EBIT
STXS 2023-12-29 4.8 7.6 -6.7 -6.2
STXS 2023-12-28 4.8 7.6 -6.7 -6.2
STXS 2023-12-27 4.7 7.4 -6.6 -6.0
STXS 2023-12-26 4.8 7.5 -6.6 -6.1
STXS 2023-12-22 5.0 8.0 -7.0 -6.5
STXS 2023-12-21 4.8 7.6 -6.7 -6.2

STXS Growth Metrics

    Its 2 year revenue growth rate is now at 20.93%.
  • Its 4 year net cashflow from operations growth rate is now at 6.66%.
  • Its year over year net cashflow from operations growth rate is now at -192.75%.
Over the past 33 months, STXS's revenue has gone up $183,880.

The table below shows STXS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 29.08643 -7.918919 -18.83483
2022-06-30 30.53588 -6.005304 -18.53611
2022-03-31 33.4353 -4.833745 -14.61271
2021-12-31 35.02086 -2.945911 -12.06065
2021-09-30 33.60519 -0.582029 -9.889141
2021-06-30 33.20232 -0.445619 -6.847937

STXS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • STXS has a Quality Grade of B, ranking ahead of 89.02% of graded US stocks.
  • STXS's asset turnover comes in at 0.581 -- ranking 75th of 186 Medical Equipment stocks.
  • FONR, SMLR, and KIDS are the stocks whose asset turnover ratios are most correlated with STXS.

The table below shows STXS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.581 0.676 -2.014
2021-03-31 0.516 0.684 -1.715
2020-12-31 0.504 0.712 -1.512
2020-09-30 0.536 0.708 -1.279
2020-06-30 0.565 0.786 -0.976
2020-03-31 0.739 0.795 -0.864

Stereotaxis (STXS) Company Bio


Stereotaxis Inc. designs, manufactures, and markets advanced cardiology instrument control system for use in the cath lab that is used in the treatment of coronary artery disease and arrhythmias. The Company markets Stereotaxis System in the United States and Europe.


STXS Latest News Stream


Event/Time News Detail
Loading, please wait...

STXS Latest Social Stream


Loading social stream, please wait...

View Full STXS Social Stream

Latest STXS News From Around the Web

Below are the latest news stories about STEREOTAXIS INC that investors may wish to consider to help them evaluate STXS as an investment opportunity.

Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients

LEXINGTON, Ky. and ST. LOUIS, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, and Baptist Health Lexington, a leading health provider in Kentucky, today announced that physicians have built upon their two-decades of leadership in robotic heart care with the successful treatment of first patients using the newest advancement in the technology, the Genesis Robotic Magnetic Navigation (RMN) System. Electrop

Yahoo | November 28, 2023

Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare Conference

ST. LOUIS, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Piper Sandler 35th Annual Healthcare Conference. Mr. Fischel will present on Stereotaxis’ business and technology during a Fireside Discussion on Thursday, November 30, 2023, at 1:30 pm ET. Mr. Fischel will be available for one-on-one meetings that sam

Yahoo | November 20, 2023

Stereotaxis, Inc. (AMEX:STXS) Q3 2023 Earnings Call Transcript

Stereotaxis, Inc. (AMEX:STXS) Q3 2023 Earnings Call Transcript November 9, 2023 Stereotaxis, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.05. Operator: Good morning. Thank you for joining us for Stereotaxis’ Third Quarter 2023 Earnings Conference Call. Certain statements during the conference call and question-and-answer period to follow may relate to […]

Yahoo | November 10, 2023

Q3 2023 Stereotaxis Inc Earnings Call

Q3 2023 Stereotaxis Inc Earnings Call

Yahoo | November 10, 2023

Stereotaxis Inc (STXS) Reports Modest Revenue Growth in Q3 2023 Amid Strategic Advances

Financial Discipline and Innovation Strategy Drive Third Quarter Results

Yahoo | November 9, 2023

Read More 'STXS' Stories Here

STXS Price Returns

1-mo 25.00%
3-mo 52.54%
6-mo N/A
1-year 10.66%
3-year -63.76%
5-year 37.76%
YTD 54.29%
2023 -15.46%
2022 -66.61%
2021 21.81%
2020 -3.78%
2019 389.36%

Continue Researching STXS

Want to see what other sources are saying about Stereotaxis Inc's financials and stock price? Try the links below:

Stereotaxis Inc (STXS) Stock Price | Nasdaq
Stereotaxis Inc (STXS) Stock Quote, History and News - Yahoo Finance
Stereotaxis Inc (STXS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!